38671-78-2

Basic information

• Product Name: Silane, trimethyl[(4-methyl-1-cyclohexen-1-yl)oxy]-
• CAS NO: 38671-78-2
• Molecular Formula: C10H20OSi
• Molecular Weight: 184.354
• Mol File: 38671-78-2.mol

Chemical Properties

• CAS DataBase Reference: Silane, trimethyl[(4-methyl-1-cyclohexen-1-yl)oxy]-(CAS DataBase Reference)
• NIST Chemistry Reference: Silane, trimethyl[(4-methyl-1-cyclohexen-1-yl)oxy]-(38671-78-2)
• EPA Substance Registry System: Silane, trimethyl[(4-methyl-1-cyclohexen-1-yl)oxy]-(38671-78-2)

Safety Data

• Hazardous Substances Data: 38671-78-2(Hazardous Substances Data)

Upstream product

• 27607-77-8 trimethylsilyl trifluoromethanesulfonate 
• 589-92-4 1-methylcyclohexan-4-one 
• 108-18-9 diisopropylamine 
• 10416-59-8 N,O-bis-(trimethylsilyl)-acetamide 
• 75-77-4 chloro-trimethyl-silane 

Downstream Products

• 41031-35-0 cis-2-(1-Adamantyl)-4-methylcyclohexanon 
• 41031-35-0 trans-2-(1-Adamantyl)-4-methylcyclohexanon 
• 91967-83-8 6-Methyl-Δ^1,9-octalon-(2) 
• 132331-62-5 4-Methyl-2-(3-oxo-butyl)-cyclohexanone 
• 132331-55-6 4-Methyl-2-((Z)-3-phenylsulfanyl-hept-2-enyl)-cyclohexanone 
• 112825-39-5 4-[(S)-2-Hydroxy-2-((1S,5S)-5-methyl-2-oxo-cyclohexyl)-ethyl]-1-phenyl-piperidine-2,6-dione 
• 27579-55-1 2-bromo-4-methylcyclohexanone 
• 244785-22-6 C₁₃H₁₅NO₃ 
• 75337-05-2 4-methyl-2-cyclohexenone 
• 7496-50-6 2-amino-6-methyl-4,5,6,7-tetrahydrobenzothiazol-7-one 
• 22422-17-9 1-acetoxy-4-methylcyclohexene 
• 103319-12-6 2-acetyl-4-methyl-cyclohexanone 
• 71436-86-7 2-tert-butyl-4-methyl-cyclohexanone 
• 118759-44-7 2-hydroxy-4-methylcyclohexanone 

Relevant articles and documents

HMOX1 inducers

The present invention is related to compounds of structure (I) as heme oxygenase 1 (HMOX 1) inducers. The present invention is also related a method of controlling the activity or the amount, or both the activity and the amount, of heme-oxygenase 1 in a mammalian subject. The definitions of the variables are provided herein.

Palladium-Mediated Remote Functionalization in γ- And ?-Arylations and Alkenylations of Unblocked Cyclic Enones

We report herein an extensive investigation of simple and regioselective endo- as well as exo-γ-arylations of silyl-dienol ethers of unblocked cyclic enones with the utilization of palladium-catalyzed, modified Kuwajima-Urabe conditions. We have also successfully explored a new exo-?-arylation of silyl-trienol ethers of π-extended cyclic enones. In addition, we also report, herein, exclusive γ- and ?-alkenylation of silyl-dienol and silyl-trienol ethers of cyclic enones.

A Solvent-Free Reaction for Silyl Enol Ethers Synthesis

Silyl enol ethers are extremely useful nucleophilic intermediates for chemical transformations because they are synthetically versatile substrates for a wide range of C-C bond-forming reactions. Here, we present a new, mild, and solvent-free procedure for the synthesis of silyl enol ethers that employs a catalytic amount of solid-supported base and an equimolar amount of N, O -(bistrimethylsilyl)acetamide as a silylating agent.

The cinchona primary amine-catalyzed asymmetric epoxidation and hydroperoxidation of α,β-unsaturated carbonyl compounds with hydrogen peroxide

Using cinchona alkaloid-derived primary amines as catalysts and aqueous hydrogen peroxide as the oxidant, we have developed highly enantioselective Weitz-Scheffer-type epoxidation and hydroperoxidation reactions of α,β-unsaturated carbonyl compounds (up to 99.5:0.5 er). In this article, we present our full studies on this family of reactions, employing acyclic enones, 5-15-membered cyclic enones, and α-branched enals as substrates. In addition to an expanded scope, synthetic applications of the products are presented. We also report detailed mechanistic investigations of the catalytic intermediates, structure-activity relationships of the cinchona amine catalyst, and rationalization of the absolute stereoselectivity by NMR spectroscopic studies and DFT calculations.

Di-tert-butylmagnesium as an atom-efficient, carbon-centred base reagent for the preparation of silyl enol ethers from ketones

Di-tert-butylmagnesium has been found to be a reactive, yet non-nucleophilic and non-reductive, carbon-centred base for the deprotonation of a series of ketones. This reagent demonstrates equally high reactivity when used as either the pre-formed reagent, or in a more accessible one-pot protocol from the parent Grignard reagent, and offers improved atom-efficiency over more traditionally employed bases. Georg Thieme Verlag Stuttgart.

Preventive and/or Therapeutic Agent for Diabetic Vascular Disorder and Respiratory Disorder

The present invention provides preventive and/or therapeutic agents for either one, or both, of a diabetic vascular disorder and a diabetic respiratory disorder comprising, as an active ingredient, a cyclohexenone long chain alcohol compound represented b

Synthesis of 1,2,3,4-tetrahydrocarbazoles and related tricyclic indoles

Reduction of 2-(2-nitrophenyl)-2-cyclohexene-1-ones using palladium on carbon under 1 atm of hydrogen gas at ambient temperature affords 1,2,3,4-tetrahydrocarbazoles in excellent isolated yields. The starting materials were prepared by intermolecular Stille coupling of 2-iodo-2-cyclohexen-1-ones with 2-(tributylstannyl)-1-nitrobenzenes.

Bismesitylmagnesium: A thermally stable and non-nucleophilic carbon-centred base reagent for the efficient preparation of silyl enol ethers

Bismesitylmagnesium has been established as an accessible, practical, convenient, and non-nucleophilic carbon-centred base reagent for efficient access to silyl enol ethers from a series of ketone substrates at readily utilisable temperatures. The Royal Society of Chemistry.

Synthesis of 5-substituted 4,5,6,7-tetrahydroindoles from cyclohexanones

5-Substituted 4,5,6,7-tetrahydroindoles were prepared from 4-substituted cyclohexanones in three steps: conversion to an enol silyl ether, introduction of a formylmethyl group at 2-C, and the Paal-Knorr pyrrole synthesis by reacting the 1,4-dicarbonyl compounds with ammonia. The substituents are H, methyl, ethyl, tert-butyl, methoxy, and phenyl.

THERAPEUTIC AGENT FOR SENSORY ABNORMALITY

The present invention provides therapeutic agents for sensory disorders represented by the following formula (1): [wherein R1, R2, and R3 each represent a hydrogen atom or a methyl group, and X represents a linear or branc